High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Research

• Publication date

  2005-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.0000199272.59432.5bPMID 16339487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of shear stress in the pathogenesis of atherosclerosis

  2005cited by this paper
• The role of shear stress in the pathogenesis of atherosclerosis

  2005cited by this paper
• Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.

  2005cited by this paper
• Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids

  2004cited by this paper
• Thromboxane A2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor–Induced Endothelial Cell Differentiation and Migration

  2004cited by this paper
• Antiinflammatory Properties of HDL

  2004cited by this paper
• Small Interfering RNA-mediated Down-regulation of Caveolin-1 Differentially Modulates Signaling Pathways in Endothelial Cells*

  2004cited by this paper
• High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation

  2004cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004cited by this paper
• High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation.

  2004cited by this paper
• High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases*

  2003cited by this paper
• High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors

  2003cited by this paper
• Cell Migration: Integrating Signals from Front to Back

  2003cited by this paper
• Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury

  2003cited by this paper
• Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways

  2003cited by this paper
• Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase Akt Pathway Mediates Nitric Oxide-Induced Endothelial Cell Migration and Angiogenesis

  2003cited by this paper
• The lamellipodium: where motility begins.

  2002cited by this paper
• Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E-Deficient Mice

  2002cited by this paper
• Regulation of endothelial nitric oxide synthase: location, location, location.

  2002cited by this paper
• Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain.

  2001cited by this paper
• Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-α but Not Estrogen Receptor-β

  2001cited by this paper
• Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-&agr; but Not Estrogen Receptor-&bgr;

  2001cited by this paper
• Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables.

  2001cited by this paper
• Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.

  2001cited by this paper
• Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL

  2001cited by this paper
• Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E—Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content

  2001cited by this paper
• Apoptosis in the vascular wall and atherosclerosis

  2001cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry.

  2000cited by this paper
• Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

  2000cited by this paper
• High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae*

  2000cited by this paper
• Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.

  1999cited by this paper
• High density lipoprotein receptors, binding proteins, and ligands.

  1999cited by this paper
• Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface*

  1999cited by this paper
• Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

  1999cited by this paper
• Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.

  1999cited by this paper
• The antiatherogenic role of high-density lipoprotein cholesterol.

  1998cited by this paper
• Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration.

  1998cited by this paper
• A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.

  1997cited by this paper
• Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.

  1997cited by this paper
• Endothelial injury in transgenic (mRen-2)27 hypertensive rats.

  1997cited by this paper
• Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

  1997cited by this paper
• Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice.

  1997cited by this paper
• Elimination of Cholesterol in Macrophages and Endothelial Cells by the Sterol 27-Hydroxylase Mechanism

  1997cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma.

  1996cited by this paper
• Specific Phospholipid Association with Apolipoprotein A-I Stimulates Cholesterol Efflux from Human Fibroblasts

  1996cited by this paper
• High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor.

  1994cited by this paper
• Repeated endothelial removal augments intimal thickening and attenuates EDRF release.

  1994cited by this paper
• Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior.

  1992cited by this paper
• The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

  1992cited by this paper
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

  1992cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• Single vertical spin density gradient ultracentrifugation.

  1986cited by this paper

• Predictive Value of Monocyte to High-Density Lipoprotein Cholesterol Ratio for Target Lesion Revascularization in Patients With Drug-Eluting Stent Implantation

  2025cites this paper
• Cell apoptosis in ischemic stroke: Focus on lipid metabolism.

  2025cites this paper
• Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary syndrome

  2025cites this paper
• Risk factors of mortality among heart failure patients in Jordan: the Jordanian Heart Failure Registry (JoHFR)

  2025cites this paper
• Oxidized high‐density lipoprotein associates with cardiometabolic dysfunction in coronary artery disease and acute coronary syndrome

  2025cites this paper
• Endothelial SR-B1 is dispensable for thermogenesis but promotes selective cholesterol uptake in brown adipose tissue

  2025cites this paper
• Blood plasma proteomics for detecting potential biomarkers for tick resistance in a tropically adapted beef cattle breed

  2025cites this paper
• Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease

  2025cites this paper
• Protective and Regenerative Effects of Reconstituted HDL on Human Rotator Cuff Fibroblasts under Hypoxia: An In Vitro Study

  2024cites this paper
• Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways

  2024cites this paper
• Sex and Age Differences in the Impact of Metabolic Syndrome on Heart Failure Development

  2024cites this paper
• The Molecular Bases of Anti-Oxidative and Anti-Inflammatory Properties of Paraoxonase 1

  2024cites this paper
• Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1

  2024cites this paper
• Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia

  2024cites this paper
• Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris

  2024cites this paper
• Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding scavenger receptor B1

  2024cites this paper
• Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin /+‐induced colorectal cancer

  2023cites this paper
• Analysis of Intestinal Metabolites in SR−B1 Knockout Mice via Ultra−Performance Liquid Chromatography Quadrupole Time−of−Flight Mass Spectrometry

  2023cites this paper
• Proteomic Exploration of Paraoxonase 1 Function in Health and Disease

  2023cites this paper
• Mechanistic insights into the anti-restenotic effects of HSP27 and HO1 modulated by reconstituted HDL on neointimal hyperplasia

  2023cites this paper
• Update of HDL in atherosclerotic cardiovascular disease.

  2023cites this paper
• Extensive diet-induced atherosclerosis in scavenger receptor class B type 1-deficient mice is associated with substantial leukocytosis and elevated vascular cell adhesion molecule-1 expression in coronary artery endothelium

  2023cites this paper
• SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor

  2022cites this paper
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

  2022cites this paper
• Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review

  2022cites this paper
• Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages

  2022cites this paper
• HDL and Endothelial Function.

  2022cites this paper
• HDL and Scavenger Receptor Class B Type I (SRBI).

  2022cites this paper
• HDL Is Not Dead Yet

  2022cites this paper
• Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1

  2022cites this paper
• Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention

  2022cites this paper
• PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation

  2022cites this paper
• Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease

  2022cites this paper
• The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology

  2022cites this paper
• HDL Composition, Heart Failure, and Its Comorbidities

  2022cites this paper
• Possible effects of Treponema pallidum infection on human vascular endothelial cells

  2022cites this paper
• Role of high-density lipoproteins in cardioprotection and in reverse remodeling: therapeutic implications.

  2021cites this paper
• Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma.

  2021cites this paper
• Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK.

  2021cites this paper
• The miR-23–27–24 cluster: an emerging target in NAFLD pathogenesis

  2021cites this paper
• High-density lipoproteins and immune response: A review.

  2021cites this paper
• Expression of SR-B1 receptor in breast cancer cell lines, MDAMB-468 and MCF-7: Effect on cell proliferation and apoptosis

  2021cites this paper
• High-density lipoprotein: a double-edged sword in cardiovascular physiology and pathophysiology

  2021cites this paper
• The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions

  2021cites this paper
• Blood derived extracellular vesicles as regenerative medicine therapeutics.

  2021cites this paper
• Τhe Antioxidant Function of HDL in Atherosclerosis

  2020cites this paper
• High-Density Lipoprotein-Targeted Therapies for Heart Failure

  2020cites this paper
• Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis

  2020cites this paper
• Gestational Diabetes Type 2: Variation in High-Density Lipoproteins Composition and Function

  2020cites this paper
• High-Density Lipoproteins and Cardiovascular Disease

  2020cites this paper
• Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients

  2020cites this paper
• High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity

  2020cites this paper
• The Anti-inflammatory and Proangiogenic Properties of High-Density Lipoproteins: An Emerging Role in Diabetic Wound Healing

  2020cites this paper
• Structure–function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk

  2020cites this paper
• Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

  2019cites this paper
• Mutual Influences between Nitric Oxide and Paraoxonase 1

  2019cites this paper
• Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.

  2019cites this paper
• Relationship Between HDL Functional Characteristics and Cardiovascular Health and Potential Impact of Dietary Patterns: A Narrative Review

  2019cites this paper
• Lipoprotein Receptor Signaling in Atherosclerosis.

  2019cites this paper
• Effects of high-density lipoprotein from patients with chronic kidney disease on endothelial function

  2019influential citation
• HDL cholesterol and ASCVD risk stratification: A debate.

  2019cites this paper
• Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein‐treated endothelial progenitor cells: a novel index for the prediction of HDL functionality

  2019cites this paper
• Scavenger receptor Class B type I as a potential risk stratification biomarker and therapeutic target in cardiovascular disease

  2019cites this paper
• Scavenger Receptor Class B type 1 (SR-B1) and the modifiable risk factors of stroke

  2019cites this paper
• Translating Evidence of HDL and Plaque Regression.

  2018cites this paper
• High‐density lipoprotein functionality and breast cancer: A potential therapeutic target

  2018cites this paper
• The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis

  2018cites this paper
• Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis

  2018cites this paper
• VEGFR2 is activated by high‐density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia

  2018cites this paper
• PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.

  2018cites this paper
• HDL ( High-Density Lipoproteins ) and Apo ( Apolipoprotein ) A-I Improve Stent Biocompatibility Recent Evidence From Experimental Models and Clinical Studies

  2018cites this paper
• Human circular RNA‑0054633 regulates high glucose‑induced vascular endothelial cell dysfunction through the microRNA‑218/roundabout 1 and microRNA‑218/heme oxygenase‑1 axes.

  2018cites this paper
• The High Density Lipoprotein Cholesterol Hypothesis Revisited

  2018cites this paper
• High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.

  2018cites this paper
• Title Signalling pathway involving GULP , MAPK and Rac 1 for SR-BI-inducedphagocytosis of apoptotic cells

  2017cites this paper
• Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1

  2017cites this paper
• Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins

  2017cites this paper
• SR-BI as target in atherosclerosis and cardiovascular disease - A comprehensive appraisal of the cellular functions of SR-BI in physiology and disease.

  2017cites this paper
• Atheromarkers of high-density lipoproteins. Part 1. High-density lipoproteins: Structure, composition, physicochemical and physiological antiatherogenic properties, their mechanisms and markers (a review of literature)

  2017cites this paper
• S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization[S]

  2017cites this paper
• High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes

  2017cites this paper
• Regulación de la funcionalidad de células progenitoras endoteliales humanas tempranas a través del receptor ecto-F1-ATPasa, vía síntesis de óxido nítrico

  2017influential citation
• SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis.

  2017cites this paper
• Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.

  2017cites this paper
• Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition

  2017cites this paper
• PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 Receptors

  2017cites this paper
• Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis

  2017cites this paper
• Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes

  2016cites this paper
• Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy.

  2016cites this paper
• Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.

  2016cites this paper
• Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues

  2016cites this paper
• Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris.

  2016cites this paper
• Petri Kresanov – Oxidized HDL lipids and the risk for atherosclerosis

  2016influential citation
• Liver disease alters high-density lipoprotein composition, metabolism and function.

  2016cites this paper
• A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.

  2016cites this paper
• ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice

  2016cites this paper
• High-Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor Class B Type I

  2016cites this paper
• PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway

  2016cites this paper
• High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma

  2016cites this paper
• CARDIOPROTECTION BY HIGH DENSITY LIPOPROTEIN IS MEDIATED BY THE SCAVENGER RECEPTOR CLASS B TYPE 1

  2016cites this paper